| Literature DB >> 29267478 |
Moustafa Abdelaal Hegazi1,2, Sommen Manou3, Hazem Sakr4, Guy Van Camp3.
Abstract
Inherited Palmoplantar Keratodermas are rare disorders of genodermatosis that are conventionally regarded as autosomal dominant in inheritance with extensive clinical and genetic heterogeneity. This is the first report of a unique autosomal recessive Inherited Palmoplantar keratoderma -sensorineural hearing loss syndrome which has not been reported before in 3 siblings of a large consanguineous family. The patients presented unique clinical features that were different from other known Inherited Palmoplantar Keratodermas -hearing loss syndromes. Mutations in GJB2 or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing. Moreover, the pathogenic mutation could not be identified using whole exome sequencing. Other known Inherited Palmoplantar keratoderma syndromes were excluded based on both clinical criteria and genetic analysis.Entities:
Mesh:
Year: 2017 PMID: 29267478 PMCID: PMC5726709 DOI: 10.1590/abd1806-4841.20176235
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Figure 1Hands and feet of the patient 1. A Bilateral symmetrical diffuse planter waxy yellowish hyperkeratosis of the feet, more severe in pressure sites, less severe in the plantar arch, and associated with deep fissures and cracks all over the sole. B Asymmetrically striate and focal hyperkeratosis in both palmar surfaces without significant nail changes
Figure 2Hands and feet of the patient 2. A - Bilateral symmetrical diffuse waxy yellowish hyperkeratosis with cracks in both plantar aspects of the soles. B - Warty papules on the knuckles of the dorsal aspect of the big toes. Note the dystrophic nail changes in the form of onychographosis (hyperkeratotic and grossly thickened nail plates) which was more severe in both big toes, but less severe in the small toes. C - Bilateral asymmetrical hyperkeratosis in the form of punctate keratoderma and focal warty keratotic papules in the palmar surface of the fingers, mainly against the interphalangeal and metacarpophalangeal joints. D - Deformed nails of both hands (non-specific nail changes)
Figure 3Hands and feet of the patient 3. A - Soles and toes with characteristics similar to patient 2 (see fig. 2 for description). B - Hyperkeratotic projections onto normal skin at the medial aspect of big toe and first web space. C - Bilateral asymmetrical hyperkeratosis in the form of warty keratotic papules in the palmar surface of both hands and fingers
List of known causative genes for diverse PPK syndromes, which might be potential candidate genes for the PPK-HL syndrome in this family and the percentage of exonic bases of the corresponding gene that are covered more than 10x and 30x
| Gene | Syndrome | Coverage 10x | Coverage 30x |
|---|---|---|---|
| KRT1 | Non-epidermolytic PPK ( Unna-Thost type);
| 23.73% | 19.46% |
| KRT9 | Epidermolytic PPK, Vorner type | 100.00% | 92.08% |
| GJB3 | Erytherokeratoderma variabilis | 97.45% | 88.83% |
| GJB4 | Erytherokeratoderma variabilis | 97.96% | 79.04% |
| GJA1 | Oculodentodigital dysplasia | 99.90% | 89.41% |
| LOR | Ichthyotic variant Vohwinkel syndrome | 97.45% | 72.25% |
| SLURP1 | Mal de Meleda | 100.00% | 100.00% |
| CTSC | Papillon-Lefevre syndrome | 96.84% | 49.69% |
| DSP | Striate PPK, Brunauer-Fohs-Siemens syndrome | 100.00% | 73.16% |
| DSG1 | Striate PPK, Brunauer-Fohs-Siemens syndrome | 98.30% | 52.20% |
| JUP | PPK | 97.37% | 86.10% |
| DSC1 | PPK | 100.00% | 81.90% |
| DSC2 | PPK | 70.00% | 84.96% |
| DSC3 | PPK | 100.00% | 93.28% |
| KRT6A | PPK | 100.00% | 98.60% |
| KRT6B | PPK | 100.00% | 94.61% |
| KRT6C | PPK | 100.00% | 87.14% |
| KRT16 | PPK | 17.75% | 7.60% |
| KRT17 | PPK | 100.00% | 70.24% |
| TRPV3 | Olmsted syndrome phenotype | 99.54% | 65.50% |
WES identified experimentally validated variants using Sanger sequencing
| Gene | Transcript | Variant type | gDNA position | cDNA position | Protein position | Zygosity |
|---|---|---|---|---|---|---|
| PLCD3 | NM_133373 | Frameshift substitution | chr17:43192550 | c.1622_1623insT | p.Leu542Thrfs*105 | 1|1 |
| KIAA1549L | NM_012194 | Non-synonymous | chr11:33564890 | c.890C>T | p.Thr297Ile | 1|1 |
| USH2A | NM_206933 | Frameshift substitution | chr1:216073489 | c.7522delT | p.Arg2509Glyfs*19 | 0|1 |
| Non-synonymous | chr1:216073491 | c.7520T>A | p.Met2507Lys | 0|1 | ||
| NR1I2 | NM_022002 | Non-synonymous | chr3:119526149 | c.169G>A | p.Glu57Lys | 0|1 |
| CMYA5 | NM_153610 | Non-synonymous | chr5:79032067 | c.7479G>T | p.Lys2493Asn | 0|1 |
| ROS1 | NM_002944 | Non-synonymous | chr6:117707022 | c.2128A>G | p.Met710Val | 0|1 |
| ECT2L | NM_001077706 | Non-synonymous | chr6:139170460 | c.958G>A | p.Val320Ile | 0|1 |
| PION | NM_017439 | Non-synonymous | chr7:77011932 | c.485C>A | p.Pro162His | 0|1 |
| TG | NM_003235 | Non-synonymous | chr8:133918945 | c.3647C>T | p.Pro1216Leu | 0|1 |
| Non-synonymous | chr9:131020422 | c.2264G>A | p.Arg755His | 0|1 | ||
| GOLGA2 | NM_004486 | Non-frameshift | chr9:131020795 | c.2144_2146del | p.Glu709del | 1|1 |
| SURF6 | NM_006753 | Non-synonymous | chr9:136199389 | c.601A>C | p.Asn201His | 0|1 |
| ZNF438 | NM_001143766 | Non-synonymous | chr10:31133916 | c.2461G>A | p.Glu821Lys | 0|1 |
| ANKRD30A | NM_052997 | Non-synonymous | chr10:37490239 | c.2687G>A | p.Ser896Asn | 0|1 |
| PLEKHG6 | NM_018173 | Start loss Non- | chr12:6421395 | c.3G>A | NRF p.Pro635His | 0|1 |
| DNAH3 | NM_017539 | Non-synonymous | chr16:20966256 | c.10950C>A | p.Asp3650Glu | 0|1 |
| ZNF469 | NM_001127464 | Non-synonymous | chr16:88501489 | c.7527G>C | p.Glu2509Asp | 0|1 |
| ABCA10 | NM_080282 | Frameshift substitution | chr17:67150465 | c.3697_3698in- | p.Glu1232_Va- | 0|1 |
| Frameshift substitution | chr17:67190117 | c.1357_1358del | p.Ile453Leufs*2 | 0|1 | ||
| RNF213 | NM_001256071 | Non-synonymous | chr17:78264436 | c.1180A>G | p.Asn394Asp | 0|1 |
| ZIM3 | NM_052882 | Non-synonymous | chr19:57646318 | c.1387G>A | p.Val463Ile | 0|1 |
NRF: loss of start codon resulting in the activation of potential downstream translation initiation site with new reading frame, gDNA: genomic DNA, cDNA: copy DNA, 1|1: homozygous, 0|1: compound heterozygous